TRexBio Expands Leadership Team with Appointments of Ariella Kelman, M.D., as Chief Medical Officer and Brandon Hants, MBA, as Chief Financial Officer New appointments position TRexBio for clinical execution and company evolution as lead TNFR2 agonist program, TRB-061, is poised to enter the clinic South San Francisco, Calif., April 8, 2025 – TRex Bio, Inc. […] The post TRexBio Expands Leadership Team with Appointments of Ariella Kelman, M.D., as Chief Medical Officer and Brandon Hants, MBA, as Chief Financial Officer appeared first on TrexBio .